Centre for Research at the CHUS
Medical imaging benefiting preclinical and clinical studies
A world leader in medical imaging, the Centre for Research at the CHUS (CRCHUS) conducts its early-stage clinical research activities at two CIUSSS sites in the Estrie region – the CHUS Hôpital Fleurimont and the Sherbrooke Hôtel-Dieu. Serving a population of more than 500,000 people in the Estrie region of Quebec, the CRCHUS stands out for the synergy that exists among its teams in basic, clinical, epidemiological and evaluative research.
More specifically, over the years, the CRCHUS has built an early-stage medical imaging clinical research infrastructure worthy of the talented experts who work there. The CRCHUS’s Sherbrooke Molecular Imaging Centre (CIMS), an imaging centre of excellence among the most highly developed in the world, has recognized expertise in the development of technologies and radiotracers, as well as in positron emission tomography (PET), magnetic resonance (MRI) and computed tomography (CT) imaging.
Areas of expertise
Cancer, diabetes, cardiovascular disease, pain, medical imaging, mother/child health and population health.
Design and operation of new preclinical tracers and biomedical instruments.
- Preclinical studies and phase I to IV clinical studies
- Experimental design of clinical studies and ethical oversight
- Evaluation of radiotracers and radiopharmaceuticals with two cyclotrons and a full range of radiochemistry services
- Cancer detection, staging and therapeutic monitoring
- Metabolic studies: diabetes and cancer
- Clinical pharmacokinetic modelling
- Dosimetry assessment
- Two cyclotrons, including a TR-24, to produce positron emission tomography (PET) tracers
- Pediatric research area, two polysomnography rooms, a gymnasium, a physical exertion laboratory, observation and meeting rooms, a pharmacy and a laboratory for the processing and shipping of biological specimens.
Centre for Research at the CHUS video: https://www.youtube.com/watch?v=pdGTJinroLE&t=1s